NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease

NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease

Abstract Background Intravenous iron is often used to treat iron deficiency anaemia in non-dialysis chronic kidney disease (ND-CKD), but the optimal dosing regimen remains unclear. We evaluated the impact of high- versus low-dose intravenous iron isomaltoside on the probability of retreatment with i...

Full description

Bibliographic Details
Main Authors: Philip A. Kalra, Sunil Bhandari, Michael Spyridon, Rachel Davison, Sarah Lawman, Ashraf Mikhail, David Reaich, Nick Pritchard, Kieran McCafferty, Jason Moore
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Nephrology
Subjects:
Anaemia
Chronic kidney disease
Ferric derisomaltose
Intravenous iron
Iron deficiency
Iron isomaltoside 1000
Online Access:https://doi.org/10.1186/s12882-020-02180-2

Internet

https://doi.org/10.1186/s12882-020-02180-2

Similar Items